Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more
Ortin Global Limited (ORTINGLOBE) - Total Assets
Latest total assets as of September 2025: ₹38.26 Million INR
Based on the latest financial reports, Ortin Global Limited (ORTINGLOBE) holds total assets worth ₹38.26 Million INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ortin Global Limited - Total Assets Trend (2021–2025)
This chart illustrates how Ortin Global Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ortin Global Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Ortin Global Limited's total assets of ₹38.26 Million consist of 88.4% current assets and 11.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 9.9% |
| Accounts Receivable | ₹2.63 Million | 7.0% |
| Inventory | ₹198.00K | 0.5% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹0.00 | 0.0% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Ortin Global Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ortin Global Limited's current assets represent 88.4% of total assets in 2025, an increase from 28.8% in 2021.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2025, up from 0.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 7.0% of total assets.
Ortin Global Limited Competitors by Total Assets
Key competitors of Ortin Global Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Ortin Global Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Ortin Global Limited generates 0.09x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ortin Global Limited is currently not profitable relative to its asset base.
Ortin Global Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.09 | 2.35 | 0.67 |
| Quick Ratio | 2.08 | 2.35 | 0.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹17.34 Million | ₹ 21.39 Million | ₹ -18.33 Million |
Ortin Global Limited - Advanced Valuation Insights
This section examines the relationship between Ortin Global Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.32 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -43.3% |
| Total Assets | ₹37.81 Million |
| Market Capitalization | $994.66K USD |
Valuation Analysis
Below Book Valuation: The market values Ortin Global Limited's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Ortin Global Limited's assets decreased by 43.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ortin Global Limited (2021–2025)
The table below shows the annual total assets of Ortin Global Limited from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹37.81 Million | -43.27% |
| 2024-03-31 | ₹66.64 Million | -68.56% |
| 2023-03-31 | ₹211.97 Million | +2.38% |
| 2022-03-31 | ₹207.05 Million | -2.64% |
| 2021-03-31 | ₹212.66 Million | -- |